Parkinson disease. Parkinson disease:Hemiparkinsonism Paralysis agitans
Conditions
Interventions
Intervention 1: Levodopa-C
Levodopa-C tablets as a routine treatment will be prescribed to all patients in control group with Parkinson disease and all patients will be examined by a neurologist dur
Treatment - Drugs
Levodopa-C
Levodopa-C tablets as a routine treatment will be prescribed to all patients in control group with Parkinson disease and all patients will be examined by a neurologist during hospitaliza
Vicinia faba extract
?Extract of Faba beans in four meals plus 25 gram carbidopa in one day will be subscribed to parkinsonian patients in case group under supervision of a neurologist. all of p
Sponsors
Mashhhad university of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: age more than 40 years old and stage of the Parkinson disease 1 to 3. Exclusion criteria: do not consenting to participate in the study; background movement disorder; allergy to Fava Bean; favism disorder; MAOI drugs Consumption and pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in overall clinical signs. Timepoint: Before and after drug consumption. Method of measurement: Physical Examination/ UPDR Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Levodopa level. Timepoint: before and one hour after drug Consumption. Method of measurement: quantitative measurement of Serum Levodopa level by HPLC/SPECT Method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKarim Nikkhah
Mashahd University of Medical Sciences
Outcome results
None listed